Skip to content
#data science Review Open access

Adulthood interstitial lung disease due to variants in surfactant related genes: A systematic review.

Sep 2026 · Pulmonology · Vol 32 1, pp. 2736380 · 0 citations · 60 references
Medicine

TL;DR

Adult SRG-related ILD/PF is likely under-recognised because of variable penetrance, wide age at onset, and non-specific imaging features.

Abstract

Background: Surfactant-related gene (SRG) variants are an emerging cause of interstitial lung disease/pulmonary fibrosis (ILD/PF). Accurate recognition of these disorders is relevant for diagnosis, genetic counselling, and clinical management.Reaserch question: How do SRG-associated ILD/PF present in adults, and what clinical, radiological, and histopathological features characterize their phenotype?Study design and methods: We performed a systematic review (PROSPERO CRD42024517610) to describe the clinical features, management, and outcomes of adults with SRG-related ILD/PF. PubMed, Embase, and Web of Science were searched from January 2000 to December 2024 for studies reporting adults (≥18 years) with genetically confirmed SRG variants and ILD/PF. Demographic, clinical, radiological, histological, functional, treatment, and lung transplantation (LT) data were extracted.Results: Thirty-eight studies included 162 adults carrying class 3-5 variants in SFTPA1/2 (61), SFTPC (52), ABCA3 (31), NKX2-1 (16), and SFTPB (2), including 35 novel variants. Age at diagnosis ranged from 19 to 79 years. Familial ILD predominated in SFTPA1/2, frequently associated with personal or familial lung cancer, whereas NKX2-1 variants showed thyroid and neurological involvement. Lung function typically demonstrated mild-to-moderate restriction with impaired diffusing capacity. Chest CT findings were heterogeneous and often indeterminate, while usual interstitial pneumonia was the predominant histological pattern except in ABCA3-related disease. Treatment approaches varied considerably; LT provided favourable outcomes in selected patients.Conclusion: Adult SRG-related ILD/PF is likely under-recognised because of variable penetrance, wide age at onset, and non-specific imaging features. International registries are needed to improve genotype-phenotype correlations and guide personalised management.

Read PDF

Similar papers

Open access Sep 2026

Occurrence of progressive pulmonary fibrosis and its association with survival in connective tissue disease-associated interstitial lung disease: an international retrospective cohort study

To describe real-world management of connective tissue disease-associated interstitial lung disease (CTD-ILD) and explore associations between progressive pulmonary fibrosis (PPF) onset and clinical outcomes. This international, retrospective cohort included adults with rheumatoid arthritis (RA), systemic sclerosis (SS...

J. Guiot, Xavier M. Teitsma, T. Dimitroulas et al. · 0 citations
Review Open access Sep 2026

Impact of time to diagnosis in patients with progressive fibrotic ILD: a systematic review

Abstract Introduction Progressive fibrosing interstitial lung diseases (PF-ILDs), including idiopathic pulmonary fibrosis (IPF), are characterised by irreversible fibrosis and poor prognosis. Despite the importance of timely identification, diagnostic delays remain common. This review aimed to summarise studies reporti...

Zhong-Yi Deng, Stefan Karrasch, P. Alter et al. · 0 citations
Review Open access Sep 2026

Blood-based biomarkers associated with progressive pulmonary fibrosis in idiopathic inflammatory myositis-associated interstitial lung disease: A retrospective cohort study from a respiratory center.

BACKGROUND Interstitial lung disease (ILD) is a common extramuscular manifestation of idiopathic inflammatory myopathies (IIM). Progressive pulmonary fibrosis (PPF) can develop in a subset of patients with IIM-associated interstitial lung disease (IIM-ILD) and is associated with poor outcomes. This study aimed to evalu...

M. Ishiwari, Yutaka Kono, Kenichi Kobayashi et al. · 0 citations
Review Sep 2026

Familial pulmonary fibrosis: a UK consensus framework for the investigation and management of patients and their relatives.

Background: There is a growing recognition that genetic predisposition contributes to the development of fibrotic interstitial lung disease. Adult onset monogenic disease is most commonly due to dysfunctional telomere maintenance, with a small proportion caused by surfactant biology disorders. These conditions can be a...

A. R. Bowden, D. Morris-Rosendahl, Helen Hanson et al. · 0 citations
Open access Aug 2026

Identifying predictors of systemic sclerosis-associated interstitial lung disease

Interstitial lung disease (ILD) is a major cause of morbidity and mortality in systemic sclerosis (SSc); yet, data from Middle Eastern populations remain limited. This study aimed to describe clinical characteristics, pulmonary involvement, and predictors of ILD in a Jordanian SSc cohort. A retrospective analysis was c...

F. Alnaimat, Salameh Al-Halaseh, Omar Ismail et al. · 0 citations
Review Sep 2026

Exploring the Autoimmune Spectrum of Combined Pulmonary Fibrosis and Emphysema: Inflammatory Myopathy Cases and a Systematic Review.

INTRODUCTION Combined Pulmonary Fibrosis and Emphysema (CPFE) is a syndrome characterized by the coexistence of emphysema and pulmonary fibrosis on High-Resolution Computed Tomography (HRCT), typically presenting with preserved lung volumes and markedly reduced diffusing capacity, and may occur in association with conn...

Luis Javier Cajas Santana, José S. Cortés, Julia Recalde et al. · 0 citations

Related blog posts

Microsoft Research Blog Oct 6, 2026

What AI gets wrong and what failure teaches us

Jennifer Neville did not want to go into computer science—but that’s exactly where she landed. Neville discusses the starts and stops that led to her professional sweet spot and her work identifying “surprising failures” making it hard for AI to handle complexity.  The post What AI gets wrong and what failure teaches us appeared first on Microsoft Research.

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.